MicroRNAs Are Differentially Expressed in Primary Central Nervous (CNS) and Nodal Diffuse Large B-Cell Lymphomas

被引:0
|
作者
Fischer, Lars
Hummel, Michael [2 ]
Korfel, Agnieszka [1 ]
Lenze, Dido [2 ]
Joehrens, Korinna [2 ]
Thiel, Eckhard
机构
[1] Charite, Campus Benjamin Franklin, Dept Hematol & Oncol, D-13353 Berlin, Germany
[2] Charite, Inst Pathol, D-13353 Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1144 / 1145
页数:2
相关论文
共 50 条
  • [31] MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma
    Pillar, Nir
    Bairey, Osnat
    Goldschmidt, Neta
    Fellig, Yakov
    Rosenblat, Yevgenia
    Shehtman, Itchak
    Haguel, Danielle
    Raanani, Pia
    Shomron, Noam
    Siegal, Tali
    ONCOTARGET, 2017, 8 (49) : 86020 - 86030
  • [32] Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas
    Vogt, Julia
    Wagener, Rabea
    Montesinos-Rongen, Manuel
    Ammerpohl, Ole
    Paulus, Werner
    Deckert, Martina
    Siebert, Reiner
    GENES CHROMOSOMES & CANCER, 2019, 58 (01): : 66 - 69
  • [33] Incidence and survival patterns of primary central nervous system (CNS), systemic and concurrent diffuse large B-cell lymphoma (DLBCL).
    Mukkamalla, Shiva Kumar Reddy
    Naseri, Hussain M.
    Sahai, Tanmay
    Roberts, Todd F.
    Malik, Mohsin Ilyas
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Expression of P53 and EBV-LMP correlates with survival in primary central nervous system diffuse large B-cell lymphomas (CNS-DLBCL)
    Eshoa, C
    Perkins, S
    Bunyi-Teopengco, E
    Schultz, C
    Kampalath, B
    Chivukula, M
    Chang, C
    MODERN PATHOLOGY, 2001, 14 (01) : 162A - 162A
  • [35] Comparison of clinical characteristics, immunophenotype and prognosis between primary gastrointestinal and primary nodal diffuse large B-cell lymphomas
    Zhu, Xiu
    Yin, Wen-Juan
    Chen, Guo-Ping
    Sun, Wen-Yong
    Wu, Mei-Juan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 5480 - 5488
  • [36] Audit of central nervous system (CNS) prophylaxis in patient with diffuse large B-cell lymphoma (DLBCL)
    Qadri, A. B.
    Wells, M.
    Yallop, D.
    Patten, P.
    Devereux, S.
    Marcus, R.
    Kassam, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 58 - 58
  • [37] Molecular predictors of central nervous system (CNS) recurrence in diffuse large B-cell lymphoma (DLBCL).
    Waroich, Jozal
    Olszewski, Adam J.
    Kurt, Habibe
    Vatkevich, John
    Sturtevant, Ashlee
    Patel, Nimesh
    Ollila, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Molecular predictors of central nervous system (CNS) recurrence in diffuse large B-cell lymphoma (DLBCL)
    Ollila, Thomas
    Kurt, Habibe
    Waroich, Jozal
    Vatkevich, John
    Sturtevant, Ashlee
    Patel, Nimesh
    Olszewski, Adam
    CANCER RESEARCH, 2020, 80 (16)
  • [39] Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas
    Muris, JJF
    Meijer, CJLM
    Cillessen, SAGM
    Vos, W
    Kummer, JA
    Bladergroen, BA
    Bogman, MJJT
    MacKenzie, MA
    Jiwa, NM
    van Heukelom, LHS
    Ossenkoppele, GJ
    Oudejans, JJ
    LEUKEMIA, 2004, 18 (03) : 589 - 596
  • [40] Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas
    J J F Muris
    C J L M Meijer
    S A G M Cillessen
    W Vos
    J A Kummer
    B A Bladergroen
    M J J T Bogman
    M A MacKenzie
    N M Jiwa
    L H Siegenbeek van Heukelom
    G J Ossenkoppele
    J J Oudejans
    Leukemia, 2004, 18 : 589 - 596